A previous meta-analysis showed that Pre-S deletions, C1653T in enhancer II, and T1753V and A1762T/G1764A in BCP are associated with increased risk of HCC compared with HBV without mutations (Liu et al., 2009). This evidence concerns the gene OPN1SW and hepatocellular carcinoma.